Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria is a research paper published in Alzheimer s & Dementia (2021). On theSindex it has a DataRank of 0. It has been cited 132 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30 AG066530
BrightFocus Foundation
Grant: A2021142S
Alzheimer's Association
Grant: AARGD‐16‐446038
NIA NIH HHS
Grant: P30 AG072946
NIA NIH HHS
Grant: U19 AG024904
NIA NIH HHS
Grant: P30 AG066514
NIA NIH HHS
Grant: R24 AG065163
NIA NIH HHS
Grant: R01 AG067428
NIA NIH HHS
Grant: R13 AG071313
NIMH NIH HHS
Grant: U24 MH100931
ZonMw
Grant: 733050834
NIA NIH HHS
Grant: R01 AG066471
NIA NIH HHS
Grant: R01 AG068183
NIA NIH HHS
Grant: R01 AG065110
National Science Foundation
FWCI
11.92
Citation Percentile
1.0%
Influential Citations
6
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials
Additional file 1 of Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials
Additional file 2 of Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials
Additional file 2 of Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials